109103 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression; Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic expressing industrially exogenous proteins, e.g. for pharmaceutical use, human insulin, blood factors, immunoglobulins, pseudoparticles
METHODS FOR BREAKING IMMUNOLOGICAL TOLERANCE USING MULTIPLE GUIDE RNAS
#302Protein production method
#303Transgenic mammals and methods of use thereof
#304Transgenic mammals and methods of use thereof
#305Production cell line enhancers
#306Non-human animals having a humanized signal-regulatory protein gene
#307MICE THAT MAKE VL BINDING PROTEINS
#308Mice that make Vbinding proteins
#309TRANSGENIC CHICKENS WITH AN INACTIVATED ENDOGENOUS GENE LOCUS
#310METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES
#311Animal Models and Therapeutic Molecules
#312Animal Models and Therapeutic Molecules
#313Animal models and therapeutic molecules
#314MGMT-based method for obtaining high yeilds of recombinant protein expression
#315ANIMAL MODELS AND THERAPEUTIC MOLECULES - Track 1
#316Non-human animals having a humanized signal-regulatory protein gene
#317High-throughput mouse model for optimizing antibody affinities
#318Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
#319Transgenic Animals
#320Method of using a transgenic chicken to produce exogenous proteins in its eggs
#321Method of making polyethylene glycol-modified mammalian erythropoietin in a transgenic chicken
#322Methods, Compositions and Systems for Production of Recombinant Spider Silk Polypeptides
#323Animal models and therapeutic molecules
#324TRANSGENIC PRODUCTION OF HEPARIN
#325Transgenic transchromosomal rodents for making human antibodies
#326Humanized monoclonal antibodies from a transgenic rat
#327TRANSGENIC BIRDS THAT PRODUCE CHIMERIC HUMAN IMMUNOGLOBULINS
#328Production cell line enhancers
#329Transgenic animal for production of antibodies having minimal CDRs
#330Generation of heavy-chain only antibodies in transgenic animals
#331Immunocompromised ungulates
#332Anti-dog IgE monoclonal antibody, and light-chain variable region and heavy-chain variable region of anti-dog IgE monoclonal antibody
#333Animal models and therapeutic molecules
#334Methods, compositions and systems for production of recombinant spider silk polypeptides
#335Methods compositions and systems for production of recombinant spider silk polypeptides
#336Production cell line enhancers
#337Production cell line enhancers
#338Protein production method
#339Complex chromosome engineering for production of human antibodies in transgenic animals
#340Production cell line enhancers
#341Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulins
#342Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
#343Transgenic transchromosomal rodents for making human antibodies
#344Chimaeric surrogate light chains (SLC) comprising human VpreB
#345Production of heavy chain only antibodies in transgenic mammals
#346Antibody production
#347Transgenic Non-Human Assay Vertebrates, Assays and Kits
#348Production of Transgenic Avians Using Improved Retroviral Vectors
#349Animal models and therapeutic molecules
#350Animal models and therapeutic molecules
#351Production cell line enhancers
#352Animal models and therapeutic molecules
#353Transgenic mouse homozygous for chimeric IgH locus
#354ANIMAL MODELS AND THERAPEUTIC MOLECULES
#355Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
#356ANIMAL MODELS AND THERAPEUTIC MOLECULES
#357Mice that make VL binding proteins
#358Rat having a disrupted immunoglobulin gene
#359Immunocompromised Ungulates
#360Nucleic acid construct having an ovalbumin promotor
#361HCO32 and HCO27 and related examples
#362Transgenic animal for production of antibodies having minimal CDRS
#363Protein production method
#364Transgenic trasnchromosomal rodents for making human antibodies
#365Methods for producing transgenic rodents having recombinant immunoglobulin loci
#366Transgenic chickens with an inactivated endogenous gene locus
#367GENERATION OF HEAVY-CHAIN ONLY ANTIBODIES IN TRANSGENIC ANIMALS
#368Methods, compositions and systems for production of recombinant spider silk polypeptides
#369TRANSGENIC AVIAN WHICH HAS FOREIGN GENE CONTAINING SEQUENCE ENCODING FELINE-DERIVED PROTEIN AND METHOD FOR PRODUCTION THEREOF
#370METHODS FOR PRODUCING AND USING IN VIVO PSEUDOTYPED RETROVIRUSES
#371Germ cells having inactivated endogenous immunoglobulin genes, and transgenic animals derived therefrom
#372Transgene expression in a avians
#373Transgenic transchromosomal rodents for making human antibodies
#374Transgenic transchromosomal rodents for making human antibodies
#375Methods for producing and using in vivo pseudotyped retroviruses
#376Production of human DNaseI in erythrocytes of transgenic non-human mammal using erythroid-specific promoter
#377Compositions and methods relating to genomic modifications in avian primordial germ cells